Galectin Therapeutics, Inc. (GALT)
4.05
-0.09
(-2.17%)
USD |
NASDAQ |
Sep 09, 16:00
4.05
0.00 (0.00%)
After-Hours: 17:07
Galectin Therapeutics Total Assets (Quarterly) : 14.83M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 14.83M |
| March 31, 2026 | 15.76M |
| December 31, 2025 | 19.53M |
| September 30, 2025 | 12.86M |
| June 30, 2025 | 15.60M |
| March 31, 2025 | 9.528M |
| December 31, 2024 | 17.50M |
| September 30, 2024 | 28.97M |
| June 30, 2024 | 27.66M |
| March 31, 2024 | 25.89M |
| December 31, 2023 | 28.20M |
| September 30, 2023 | 22.16M |
| June 30, 2023 | 20.08M |
| March 31, 2023 | 20.22M |
| December 31, 2022 | 21.28M |
| September 30, 2022 | 17.91M |
| June 30, 2022 | 25.89M |
| March 31, 2022 | 33.62M |
| December 31, 2021 | 41.83M |
| September 30, 2021 | 38.04M |
| June 30, 2021 | 33.40M |
| March 31, 2021 | 22.90M |
| December 31, 2020 | 29.60M |
| September 30, 2020 | 34.05M |
| June 30, 2020 | 41.32M |
| Date | Value |
|---|---|
| March 31, 2020 | 44.11M |
| December 31, 2019 | 48.47M |
| September 30, 2019 | 50.76M |
| June 30, 2019 | 53.01M |
| March 31, 2019 | 7.83M |
| December 31, 2018 | 9.006M |
| September 30, 2018 | 10.62M |
| June 30, 2018 | 11.21M |
| March 31, 2018 | 4.931M |
| December 31, 2017 | 4.161M |
| September 30, 2017 | 7.011M |
| June 30, 2017 | 9.329M |
| March 31, 2017 | 14.00M |
| December 31, 2016 | 15.80M |
| September 30, 2016 | 16.12M |
| June 30, 2016 | 18.25M |
| March 31, 2016 | 22.79M |
| December 31, 2015 | 26.41M |
| September 30, 2015 | 21.51M |
| June 30, 2015 | 26.68M |
| March 31, 2015 | 29.97M |
| December 31, 2014 | 29.68M |
| September 30, 2014 | 31.32M |
| June 30, 2014 | 34.59M |
| March 31, 2014 | 36.90M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 151.68M |
| Shareholders Equity (Quarterly) | -136.85M |
| Debt to Equity Ratio | -1.007 |
| Current Ratio | 0.0967 |
| Net Debt Paydown Yield | -1.94% |